Skip to content

Armed4Stroke: Allied Rehabilitation using Medical Devices for Stroke

Armed4Stroke: Allied Rehabilitation using Medical Devices for Stroke - Armed4Stroke

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55636
Enrollment
72
Registered
2019-04-30
Start date
2019-10-21
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acquired brain injury stroke

Interventions

The Armed4Stroke program consists of eight weeks of complementary exercise therapy done with a caregiver, supported by tele-rehabilitation, next to the usual therapy. The couple has regular face-to-

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the patient will be: 1) 21 points) 9) Sufficiently motivated for CME Inclusion criteria for the caregiver: 1) 18 years or older 2) Written informed consent 3) Able to understand the Dutch language (on sufficient level to understand instructions and complete the questionnaires) 4) Sufficiently motivated for CME 5) Medically stable and physically able to perform the exercises together with the patient.

Exclusion criteria

Exclusion criteria: For both patient and caregiver: a serious comorbidity that interferes with participation

Design outcomes

Primary

MeasureTime frame
Mobility domain of the self-reported health status following the Stroke Impact Scale (SIS version 3.0).

Secondary

MeasureTime frame
Secondary objectives are to assess the added value of the Armed4Stroke on - The length of inpatient stay in those patients that start the CME intervention during inpatient rehabilitation. - Preparedness for Caregiving Scale - Functional outcomes, such as walking speed and distance, balance and the level of independency during Activities of Daily Living (ADL) - Psychosocial measures, such as self-efficacy and anxiety and depression of patient and caregiver and quality of live.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)